Bristol-Myers Squibb And Pfizer To Present New Data On Eliquis (apixaban) At The American Heart Association Scientific Sessions 2015

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--

Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) announced today that 22 abstracts will be presented at the American Heart Association (AHA) Scientific Sessions 2015, to be held November 7-11 in Orlando, Florida. The new data, including four oral presentations, contribute to the Bristol-Myers Squibb and Pfizer Alliance’s research in nonvalvular atrial fibrillation (NVAF) and venous thromboembolism (VTE) in patients treated with Eliquis.

Help employers find you! Check out all the jobs and post your resume.

Back to news